Niagen Bioscience, Inc.
Biotechnology
Healthcare
NAGE
86.24 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
10.27
52 week high
14.14
high
10.52
52 week low
0.00
low
10.17
growth
180.99 %
previous Close
10.24
P/E ratio
market cap
837 M
div yield
0
net incoming
3.61 M
-28.72 %
net profit margin
11.60 %
-5.00 %
operating incoming
3.19 M
-33.26 %
net change in cash
4.86 M
-55.66 %
cash on hand
60.32 M
8.76 %
cost of revenue
10.89 M
-2.32 %
top